Annals of Surgical Oncology

, Volume 17, Issue 8, pp 2175–2183 | Cite as

Impact of Diabetes Mellitus on the Prognosis of Patients with Oral Squamous Cell Carcinoma: A Retrospective Cohort Study

  • Cheng-Hsien Wu
  • Tzu-Ying Wu
  • Chia-Chen Li
  • Man-Tin Lui
  • Kuo-Wei Chang
  • Shou-Yen Kao
Head and Neck Oncology

Abstract

Background

Diabetes mellitus (DM) is a prevalent chronic metabolic disease reported to affect the treatment outcomes of malignancies. This study explores the impact of diabetes on the prognosis of oral squamous cell carcinoma (OSCC).

Materials and Methods

Clinicopathological characteristics and survival in terms of overall survival (OS), recurrence-free survival (RFS), and cancer-specific survival (CSS) of patients with OSCC who underwent surgical intervention at the Taipei Veterans General Hospital between 2002 and 2005 were stratified by diabetic status and compared.

Results

Patients with DM tend to have a lower OS, RFS, and CSS compared with nondiabetics (adjusted hazard ratio [HR] = 2.22, 2.42, and 2.16, respectively) even in less aggressive tumor stages (stage I and II). In advanced tumors, diabetic patients who were not prescribed adjuvant therapy had a significantly higher recurrence rate than nondiabetic patients (HR = 2.66). However, there was no significant difference in treatment outcome in patients with locally advanced tumors amenable to receive adjuvant therapy, even with the delayed initiation of adjuvant therapy in the DM group (49.1 ± 22.3 days vs. 40.0 ± 16.6 days, P = .04). DM was also associated with a higher frequency of perineural invasion (adjusted odds ratio [OR] = 2.53).

Conclusion

DM status could be a prognostic factor for OSCC, particularly for its effect in the survival and perineural invasion. Although diabetes-associated comorbidities may impair decision making toward less aggressive therapeutic modality, adjuvant treatment may be essential for DM patients to improve their survival.

Supplementary material

10434_2010_996_MOESM1_ESM.doc (245 kb)
Supplementary material 1 (DOC 245 kb)

References

  1. 1.
    Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000;6:65–74.PubMedGoogle Scholar
  2. 2.
    Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis. 2003;9:112–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Carvalho AL, Singh B, Spiro RH, Kowalski LP, Shah JP. Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation. Head Neck. 2004;26:31–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 2006;28:107–13.CrossRefPubMedGoogle Scholar
  5. 5.
    Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711–42.CrossRefPubMedGoogle Scholar
  6. 6.
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH, Chang KW. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res. 2007;13:4378–85.CrossRefPubMedGoogle Scholar
  8. 8.
    Wu CH, Tu HF, Gong NR, Chen YW, Liu CJ, Kao SY. The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma. Oral Oncol. 2009;45:579–83.CrossRefPubMedGoogle Scholar
  9. 9.
    Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39:207–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84:417–22.CrossRefPubMedGoogle Scholar
  12. 12.
    Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol. 1998;147:816–25.PubMedGoogle Scholar
  13. 13.
    Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care. 2003;26:1752–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Ujpal M, Matos O, Bibok G, Somogyi A, Szabó G, Suba Z. Diabetes and oral tumors in Hungary: epidemiological correlations. Diabetes Care. 2004;27:770–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Ujpal M, Matos O, Bibok G, Szabo G. Incidence of diabetes mellitus in patients with malignant tumors of the oral cavity. Orv Hetil. 2002;143:2731–3.PubMedGoogle Scholar
  16. 16.
    Verlato G, Zoppini G, Bonora E, Muggeo M. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care. 2003;26:1047–51.CrossRefPubMedGoogle Scholar
  17. 17.
    Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents. Vol. VIII: IARC Scientific Publication No. 155; 2003.Google Scholar
  19. 19.
    Goutzanis L, Vairaktaris E, Yapijakis C, Kavantzas N, Nkenke E, Derka S, et al. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol. 2007;43:165–73.CrossRefPubMedGoogle Scholar
  20. 20.
    Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.Google Scholar
  21. 21.
    Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, eds. American Joint Committee on Cancer: AJCC cancer staging manual. 6th ed. New York: Springer; 2002.Google Scholar
  22. 22.
    Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167–78.CrossRefPubMedGoogle Scholar
  23. 23.
    Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42:229–39.CrossRefPubMedGoogle Scholar
  24. 24.
    Mulder GD. Wound Care Communications Network. Clinician’s Pocket Guide to Chronic Wound Repair. PA: Springhouse; 1998. p. 58–67.Google Scholar
  25. 25.
    Kramer S, Gelber RD, Snow JB, Marcial VA, Lowry LD, Davis LW, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 1987;10:19–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.CrossRefPubMedGoogle Scholar
  28. 28.
    2002 Survey on the Prevalence of Hypertension, Hyperglycemia and Hyperlipidemia in Taiwan. Bureau of Health Promotion DoH, Executive Yuan, R.O.C. (Taiwan), ed., 2003.Google Scholar
  29. 29.
    Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679–87.CrossRefPubMedGoogle Scholar
  31. 31.
    Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365–74.CrossRefPubMedGoogle Scholar
  32. 32.
    El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369–80.CrossRefPubMedGoogle Scholar
  33. 33.
    Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92:2076–83.CrossRefPubMedGoogle Scholar
  34. 34.
    Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res. 2002;105:53–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med. 1992;21:261–4.CrossRefPubMedGoogle Scholar
  36. 36.
    Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC, et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24:450–3.CrossRefPubMedGoogle Scholar
  37. 37.
    Boucher BJ, Ewen SW, Stowers JM. Betel nut (Areca catechu) consumption and the induction of glucose intolerance in adult CD1 mice and in their F1 and F2 offspring. Diabetologia. 1994;37:49–55.CrossRefPubMedGoogle Scholar
  38. 38.
    Boucher BJ, Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol. 2002;7:103–10.CrossRefPubMedGoogle Scholar
  39. 39.
    Tung TH, Chiu YH, Chen LS, Wu HM, Boucher BJ, Chen TH. A population-based study of the association between areca nut chewing and type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2). Diabetologia. 2004;47:1776–81.CrossRefPubMedGoogle Scholar
  40. 40.
    Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21:1167–72.CrossRefPubMedGoogle Scholar
  41. 41.
    Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care. 1998;21:1138–45.CrossRefPubMedGoogle Scholar
  42. 42.
    Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26:3–11.PubMedGoogle Scholar
  44. 44.
    Vikram B. Postoperative irradiation for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1990;18:267–8.PubMedGoogle Scholar
  45. 45.
    Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005;2:48–53.CrossRefPubMedGoogle Scholar
  46. 46.
    Fagan JJ, Collins B, Barnes L, D’Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:637–40.PubMedGoogle Scholar
  47. 47.
    Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:423–31.CrossRefPubMedGoogle Scholar
  48. 48.
    O’Brien CJ, Lahr CJ, Soong SJ, Gandour MJ, Jones JM, Urist MM, et al. Surgical treatment of early-stage carcinoma of the oral tongue—wound adjuvant treatment be beneficial? Head Neck Surg. 1986;8:401–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer. 1989;64:1195–202.CrossRefPubMedGoogle Scholar
  50. 50.
    Soo KC, Carter RL, O’Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope. 1986;96:1145–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Maddox WA. Hayes Martin lecture. Vicissitudes of head and neck cancer. Am J Surg. 1984;148:428–32.CrossRefPubMedGoogle Scholar
  52. 52.
    De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003;200:429–47.CrossRefPubMedGoogle Scholar
  53. 53.
    Kotelevets L, Noe V, Bruyneel E, Myssiakine E, Chastre E, Mareel M, et al. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′-kinase is a critical mediator of tumor invasion. J Biol Chem. 1998;273:14138–45.CrossRefPubMedGoogle Scholar
  54. 54.
    Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148:779–90.CrossRefPubMedGoogle Scholar
  55. 55.
    Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61:3819–25.PubMedGoogle Scholar
  56. 56.
    Tran NL, Adams DG, Vaillancourt RR, Heimark RL. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem. 2002;277:32905–14.CrossRefPubMedGoogle Scholar
  57. 57.
    Vairaktaris E, Spyridonidou S, Goutzanis L, Vylliotis A, Lazaris A, Donta I, et al. Diabetes and oral oncogenesis. Anticancer Res. 2007;27:4185–93.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2010

Authors and Affiliations

  • Cheng-Hsien Wu
    • 1
    • 3
  • Tzu-Ying Wu
    • 2
  • Chia-Chen Li
    • 2
  • Man-Tin Lui
    • 1
    • 3
  • Kuo-Wei Chang
    • 1
    • 3
  • Shou-Yen Kao
    • 1
    • 3
  1. 1.Oral and Maxillofacial Surgery, Department of StomatologyTaipei Veterans General HospitalTaipeiTaiwan, ROC
  2. 2.Division of Orthodontics, Department of StomatologyTaipei Veterans General HospitalTaipeiTaiwan, ROC
  3. 3.Faculty of Dentistry, School of DentistryNational Yang-Ming UniversityTaipeiTaiwan, ROC

Personalised recommendations